Get the latest Science News and Discoveries

Alzheimer’s drug saga prompts journal to scrutinize whistle-blowers. Publication requires complainants to disclose financial conflicts in the wake of controversy over Cassava Sciences’ experimental treatment simufilam.


Get the Android app

Or read this on r/EverythingScience

Read more on:

S

Journal

Sciences